|
|
Volumn 37, Issue 5, 2012, Pages 562-564
|
|
Adalimumab-induced medium-sized vessel vasculitis
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADALIMUMAB;
ANTINUCLEAR ANTIBODY;
COMPLEMENT COMPONENT C4;
DICLOFENAC;
DOUBLE STRANDED DNA ANTIBODY;
LA ANTIBODY;
METHOTREXATE;
NEUTROPHIL CYTOPLASMIC ANTIBODY;
RO ANTIBODY;
ADULT;
ANTIBODY TITER;
CASE REPORT;
DISEASE DURATION;
DRUG EFFICACY;
DRUG WITHDRAWAL;
ERYTHROCYTE SEDIMENTATION RATE;
FEMALE;
HISTOPATHOLOGY;
HUMAN;
LABORATORY TEST;
LETTER;
LIVEDO RETICULARIS;
MEDICAL HISTORY;
MEDIUM VESSEL VASCULITIS;
PHYSICAL EXAMINATION;
PRIORITY JOURNAL;
RASH;
RHEUMATOID ARTHRITIS;
SJOEGREN SYNDROME;
SKIN BIOPSY;
SUBCUTANEOUS TISSUE;
TREATMENT DURATION;
VASCULITIS;
ANTI-INFLAMMATORY AGENTS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
FEMALE;
HUMANS;
LEG DERMATOSES;
MIDDLE AGED;
VASCULITIS;
|
|
EID: 84862859457
PISSN: 03076938
EISSN: 13652230
Source Type: Journal
DOI: 10.1111/j.1365-2230.2011.04242.x Document Type: Letter |
|
Times cited : (5)
|
|
References (5)
|
